{"metadata":{"topics":["388 Greenwich Street","Access to information","Accountability","Accountant","Accounting","Accounting standard","Administrative law","Adverse effect","Applied ethics","Arbitral tribunal","Artificial objects","Asset","Audit","Audit committee","Auditing","Balance sheet","Bank","Banking","Bankruptcy","Board of directors","Bond (finance)","Borough","Bribery","Broadcast Standards and Practices","Brokerage firm","Business","Business economics","Business law","Business organizations","Business process management","By-law","Capital (economics)","Cash flow","Charter","Chief executive officer","Chief financial officer","City","Civil law (common law)","Civil law (legal system)","Clinical trial","Cognition","Cognitive science","Comfort letter","Common law","Common stock","Communication","Companies","Company","Comparative law","Conflict (process)","Consent","Contract","Contract law","Contractual term","Copyright","Copyright infringement","Corporate finance","Corporate governance","Corporate jargon","Corporate law","Corporate personhood","Corporation","Corporations","Corruption","Cost","Court","Covenant (law)","Credit","Credit Suisse","Creditor","Crime","Criminal justice","Criminal law","Culpability","Culture","Currency","Custom","Customer","Damages","Data","Davis Polk & Wardwell","Debenture","Debt","Declaration of war","Definition","Delaware","Delaware General Corporation Law","Deloitte","Discovery (law)","Dividend","Doctrines","Document","Documents","Domain name","Drug","Duty","Economic law","Economic sectors","Economics","Economies","Economy","Economy of the United States","Emergency","Employee stock option","Employment","Encumbrance","Entity","Environmental law","Equity (finance)","Equity (law)","Equity securities","Ethical principles","Ethics","Evidence","Exchange rate","Executive officer","Exercise","Expense","Failure","Fax","Federal government of the United States","Fee","Felony","Fiduciary","Finance","Financial Industry Regulatory Authority","Financial accounting","Financial economics","Financial law","Financial markets","Financial regulation","Financial risk","Financial services","Financial statement","Financial statements","Financial transaction","Fine (penalty)","Fiscal year","Food","Food and Drug Administration","Foreign Corrupt Practices Act","Foreign corporation","Foreign direct investment","Foreign exchange controls","Foreign exchange market","Form 10-K","Form 10-Q","Form S-1","Franchising","Fraud","General counsel","Generally Accepted Accounting Principles (United States)","Gift","Good clinical practice","Good faith","Good laboratory practice","Governance","Government","Government agencies","Government agency","Government information","Government of the United States","Government-related organizations","Gross negligence","Hedge (finance)","Human activities","Human rights","Hypothecation","Income","Indemnity","Indenture","Industries","Information","Initial public offering","Insurance","Intellectual property","Intellectual property law","Intellectual works","Intention (criminal law)","Interest","Internal Revenue Code","Internal Revenue Service","Internal audit","Internal control","International law","International relations","Invention","Investment","Investment Company Act of 1940","Investor","Issuer","Jargon","Joint venture","Judgment (law)","Judiciaries","Jurisdiction","Jurisprudence","Justice","Know-how","Knowledge","Labor dispute","Laboratory","Law","Law and economics","Law of obligations","Lawsuit","Leadership","Lease","Legal concepts","Legal doctrines and principles","Legal documents","Legal ethics","Legal fictions","Legal liability","Legal literature","Legal person","Legal writing","Liability (financial accounting)","License","Lien","Limited liability company","Limited liability partnership","Loan","Loan agreement","Lock-up period","Madison Avenue","Management","Manhattan","Market (economics)","Material adverse change","Matter","Memorandum","Metaphysics","Microeconomics","Misappropriation","Misconduct","Misdemeanor","Misrepresentation","Money","Money laundering","Morality","Mortgage law","NASDAQ","NYSE American","Nationally recognized statistical rating organization","Natural environment","Natural resources law","Negligence","Negotiation","News","Office of Foreign Assets Control","Official documents","Omission (law)","Open government","Opinion","Option (finance)","Order (exchange)","Organization","Out-of-pocket expense","Outbreak","Over-the-counter (finance)","Ownership","Par value","Partnership","Passive foreign investment company","Patent","Payment","Payments","Percentage","Personality traits","Petition","Philosophy","Poison","Policy","Political economy","Political science","Politics","Pre-clinical development","Precedent","Preferred stock","Price","Primary market","Principles","Private law","Pro rata","Professional ethics","Property","Property law","Proprietary software","Prospectus (finance)","Proxy server","Proxy statement","Public Company Accounting Oversight Board","Public administration","Public company","Public law","Public policy","Public sphere","Purchasing","Real property","Reason","Rebate (marketing)","Receipt","Records management","Registration statement","Regulation","Regulatory compliance","Reliability engineering","Research","Revenue","Rights","Risk","Risk management","Road","Roman law","Rules","Sarbanes–Oxley Act","Science","Secondary market","Securities (finance)","Securities Act of 1933","Securities Exchange Act of 1934","Securities regulation in the United States","Security (finance)","Sentence (linguistics)","Service industries","Services (economics)","Share (finance)","Shareholder","Signature","Social institutions","Social issues","Sociological theories","Sources","Stamp duty","State Security Law in Bahrain","State court (United States)","Statistics","Statute","Stock","Stock exchange","Stock market","Subsidiary","Surety","Surety bond","Surveillance","Swap (finance)","Switzerland","Tax","Tax return (United States)","Technology","Telephone","Term sheet","Terrorism","Theories of law","Tort of deceit","Toxicity","Trade","Trade secret","Trademark","Treasury","Trial","U.S. Securities and Exchange Commission","Understanding","Underwriting","United States","United States Congress","United States Department of the Treasury","United States business law","United States dollar","United States economic policy","United States federal policy","United States federal securities legislation","United States regulations","United States securities law","Urban, rural, and regional economics","Value (ethics)","Virtue","Waiver","War","Warrant (finance)","Warranty","Wire","Wire transfer","Written communication"],"person_names":["edgar","hofer gilson & lione"],"vars":{"Party":{"incorporated":"[[Party 1]]"}},"organization_names":["additional registration statement","alimera sciences, inc.","citigroup global markets inc.","commission","credit suisse securities","davis polk & wardwell","deloitte & touche llp","electronic data gathering","eleven madison avenue","final prospectus","firm securities","general disclosure package","gunderson dettmer stough villeneuve franklin & hachigian","issuer free writing","issuer free writing prospectus","limited use issuer free writing","lock-up period","lock-up securities","material united states federal tax","nasdaq global market","offered securities","other legal matters","representatives","statutory prospectus"],"agreement_id":"2daf0bf6258ac2c4132889de15de26b0211f51abccd566769f9a0531b064f587","terms":["***Applicable Law***","***Definitions***","**ALIMERA SCIENCES, INC.**","**Common Stock**","**This Agreement shall be governed by, and construed in accordance with, the laws of the State of [[Address 8: Address]]**","**UNDERWRITING AGREEMENT**","**[Insert Number of Shares]**","*Absence of Accounting Issues*","*Absence of Defaults and Conflicts Resulting from Transaction*","*Absence of Existing Defaults and Conflicts*","*Absence of Fiduciary Relationship*","*Absence of Further Requirements*","*Absence of Labor Dispute*","*Absence of Manipulation*","*Absence of Obligation to Disclose*","*Absence of Unlawful Influence.*","*Accountants’ Comfort Letter*","*Accurate Disclosure*","*Actions against Parties; Notification*","*Additional Filings*","*Additional Officer’s Certificate*","*Arms’ Length Negotiations*","*Authorization of Agreement*","*Blue Sky Qualifications*","*Certain Agreements of the Company*","*Compliance with Foreign Laws.*","*Compliance with Money Laundering Laws*","*Compliance with Securities Act Requirements*","*Conditions of the Obligations of the Underwriters*","*Continued Compliance with Securities Laws*","*Contribution*","*Counterparts*","*Default of Underwriters*","*Effectiveness of Registration Statement*","*Environmental Laws*","*FCPA.*","*Filing and Effectiveness of Registration Statement; Certain Defined Terms*","*Filing of Amendments: Response to Commission Requests*","*Financial Statements*","*Free Writing Prospectuses*","*Furnishing of Prospectuses*","*General Disclosure Package*","*Good Standing of the Company*","*Indemnification and Contribution.*","*Indemnification of Company*","*Indemnification of Underwriters by Company*","*Ineligible Issuer Status*","*Insurance*","*Intellectual Property*","*Internal Controls and Compliance with the Sarbanes-Oxley Act*","*Introductory*","*Investment Company Act*","*Issuer Free Writing Prospectuses*","*Listing*","*Litigation*","*Lock-Up Agreements*","*No Finder’s Fee*","*No Material Adverse Change in Business*","*No Material Adverse Change*","*No Other Relationship*","*Notices*","*OFAC*","*Offered Securities; Capitalization*","*Offering by Underwriters*","*Officer’s Certificate*","*Opinion of Counsel for Underwriters*","*Opinion of Counsel for the Company*","*Opinion of Patent Counsel for the Company*","*PFIC Status*","*Payment of Expenses Related to Directed Share Program.*","*Payment of Expenses*","*Possession of Licenses and Permits*","*Preclinical and Clinical Trials*","*Purchase, Sale and Delivery of Offered Securities*","*Ratings*","*Registration Rights*","*Reporting Requirements*","*Representation*","*Representations and Warranties of the Company*","*Restriction on Sale of Securities by Company*","*Rule 158*","*Statistical and Market-Related Data*","*Subsidiaries*","*Successors*","*Survival of Certain Representations and Obligations*","*Taxation*","*Term Sheets*","*Title to Property*","*Transfer Restrictions.*","*Use of Proceeds*","*Waiver*","“**430A Information**","“**Act**”","“**Additional Registration Statement**","“**Applicable Time**”","“**Audit Committee**”","“**Availability Date**”","“**Board**”","“**Closing Date**”","“**Commission**”","“**Company**”","“**Debt Repayment Triggering Event**”","“**Designated Entities**”","“**Designated Underwriter**”","“**Directed Share Program**”","“**Directed Shares**”","“**EDGAR**”","“**Effective Time**”","“**Environmental Laws**”","“**Exchange Act**”","“**Exchange Rules**”","“**Final Prospectus**”","“**Firm Securities**”","“**First Closing Date**","“**GAAP**”","“**General Disclosure Package**”","“**General Use Issuer Free Writing Prospectus**”","“**Indemnified Party**”","“**Initial Registration Statement**","“**Intellectual Property Rights**”","“**Internal Control Event**”","“**Internal Controls**”","“**Investment Company Act**”","“**Issuer Free Writing Prospectus**”","“**Licenses**”","“**Limited Use Issuer Free Writing Prospectus**”","“**Lock-Up Period**”","“**Lock-Up Securities**”","“**Material Adverse Effect**”","“**Money Laundering Laws**”","“**OFAC**”","“**Offered Securities.**”","“**Optional Closing Date**”","“**Optional Securities**”","“**PFIC**”","“**Participants**”","“**Permitted Free Writing Prospectus**","“**Registration Statement**","“**Registration Statement**”","“**Registration Statements**”","“**Representatives**”","“**Rules and Regulations**”","“**Sarbanes-Oxley**”","“**Securities Laws**”","“**Securities**”","“**Statutory Prospectus**”","“**Underwriter Indemnified Party**”","“**Underwriters**”"]}}